Intelligent Bio Solutions Inc. (NASDAQ:INBS) Sees Significant Growth in Short Interest

Intelligent Bio Solutions Inc. (NASDAQ:INBS) was the target of a large growth in short interest during the month of February. As of February 28th, there was short interest totalling 454,100 shares, a growth of 17.3% from the February 13th total of 387,100 shares. Approximately 6.8% of the company’s shares are short sold. Based on an average trading volume of 200,500 shares, the days-to-cover ratio is currently 2.3 days.

Intelligent Bio Solutions Price Performance

Shares of NASDAQ:INBS opened at $2.09 on Friday. The business has a 50-day moving average price of $1.93 and a 200 day moving average price of $1.70. Intelligent Bio Solutions has a 12-month low of $1.00 and a 12-month high of $4.64.

Intelligent Bio Solutions (NASDAQ:INBS) last issued its quarterly earnings data on Thursday, February 13th. The company reported ($0.50) earnings per share (EPS) for the quarter. The business had revenue of $610 billion for the quarter. Intelligent Bio Solutions had a negative return on equity of 146.03% and a negative net margin of 323.79%. Equities analysts predict that Intelligent Bio Solutions will post -1.25 earnings per share for the current fiscal year.

About Intelligent Bio Solutions

Intelligent Bio Solutions Inc, a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.